Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.0 EUR
−882.68 M EUR
351.33 M EUR
206.71 M
About Insmed Incorporated
Sector
Industry
CEO
William H. Lewis
Website
Headquarters
Bridgewater
Founded
1988
ISIN
US4576693075
FIGI
BBG01TNY3323
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of 1INSM is 122.0 EUR — it has decreased by −1.61% in the past 24 hours. Watch Insmed Incorporated stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Insmed Incorporated stocks are traded under the ticker 1INSM.
1INSM stock has risen by 5.17% compared to the previous week, the month change is a 25.77% rise, over the last year Insmed Incorporated has showed a 100.00% increase.
We've gathered analysts' opinions on Insmed Incorporated future price: according to them, 1INSM price has a max estimate of 206.22 EUR and a min estimate of 94.52 EUR. Watch 1INSM chart and read a more detailed Insmed Incorporated stock forecast: see what analysts think of Insmed Incorporated and suggest that you do with its stocks.
1INSM reached its all-time high on Aug 28, 2025 with the price of 116.0 EUR, and its all-time low was 57.5 EUR and was reached on May 8, 2025. View more price dynamics on 1INSM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1INSM stock is 1.64% volatile and has beta coefficient of 0.96. Track Insmed Incorporated stock price on the chart and check out the list of the most volatile stocks — is Insmed Incorporated there?
Today Insmed Incorporated has the market capitalization of 26.02 B, it has increased by 5.48% over the last week.
Yes, you can track Insmed Incorporated financials in yearly and quarterly reports right on TradingView.
Insmed Incorporated is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
1INSM earnings for the last quarter are −1.44 EUR per share, whereas the estimation was −1.10 EUR resulting in a −31.51% surprise. The estimated earnings for the next quarter are −1.15 EUR per share. See more details about Insmed Incorporated earnings.
Insmed Incorporated revenue for the last quarter amounts to 91.18 M EUR, despite the estimated figure of 88.39 M EUR. In the next quarter, revenue is expected to reach 97.96 M EUR.
1INSM net income for the last quarter is −273.08 M EUR, while the quarter before that showed −237.17 M EUR of net income which accounts for −15.14% change. Track more Insmed Incorporated financial stats to get the full picture.
No, 1INSM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 4, 2025, the company has 1.27 K employees. See our rating of the largest employees — is Insmed Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Insmed Incorporated EBITDA is −777.02 M EUR, and current EBITDA margin is −213.24%. See more stats in Insmed Incorporated financial statements.
Like other stocks, 1INSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Insmed Incorporated stock right from TradingView charts — choose your broker and connect to your account.